DeepMed Research

INSIGHTEC, INC.

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Bilateral Treatment of Medication Refractory Essential Tremor

Not Applicable

Active, not recruiting

Conditions: Essential Tremor

Interventions: Device: Exablate Model 4000 Type 1.0/1.1

First Posted Date: 2019-10-02

Last Posted Date: 2025-05-01

Lead Sponsor: InSightec

Target Recruit Count: 51

Registration Number: NCT04112381

Locations: 🇺🇸
University of Maryland, Baltimore, Maryland, United States
🇺🇸
West Virginia University, Morgantown, West Virginia, United States
🇺🇸
Stanford University, School of Medicine, Stanford, California, United States

and more 4 locations

Safety and Initial Effectiveness of Transcranial MR Guided Focused Ultrasound for the Treatment of Parkinson's Disease

Not Applicable

Conditions: Parkinson Disease

Interventions: Device: ExAblate Neuro Thalamotomy Treatment

First Posted Date: 2019-06-28

Last Posted Date: 2019-06-28

Lead Sponsor: InSightec

Target Recruit Count: 50

Registration Number: NCT04002596

Locations: 🇯🇵
Shonan Fujisawa Tokushukai Hospital, Fujisawa, Kanagawa, Japan
🇨🇳
Henan Provincial Peoples Hospital, Zhengzhou, Henan, China

Continued Access of Focal MR-Guided Focused Ultrasound for Localized Intermediate Risk Prostate Lesions

Not Applicable

Active, not recruiting

Conditions: Prostate Cancer

Interventions: Device: Exablate Prostate Treatment

First Posted Date: 2019-06-26

Last Posted Date: 2025-05-01

Lead Sponsor: InSightec

Target Recruit Count: 14

Registration Number: NCT03998657

Locations: 🇺🇸
Sperling Prostate Center, Delray Beach, Florida, United States
🇺🇸
Stanford University School of Medicine, Stanford, California, United States
🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

and more 2 locations

A Feasibility Study on the Safety and Preliminary Efficacy of Bilateral Subthalamotomy Using MRgFUS for Treatment of PD

Not Applicable

Conditions: Parkinson Disease
Neurologic Manifestations

Interventions: Device: Exablate Bilateral Subthalamotomy

First Posted Date: 2019-05-28

Last Posted Date: 2022-08-03

Lead Sponsor: InSightec

Target Recruit Count: 3

Registration Number: NCT03964272

Locations: 🇪🇸
Hospital Universitario HM Puerta Del Sur. CINAC, Móstoles, Madrid, Spain

Safety and Feasibility of ExAblate Neuro System to Perform Auto-Focusing Echo Imaging in Patients With Essential Tremor

Not Applicable

Conditions: Neurologic Manifestations
Tremor, Essential
Tremor

Interventions: Device: ExAblate

First Posted Date: 2019-05-02

Last Posted Date: 2021-09-17

Lead Sponsor: InSightec

Target Recruit Count: 20

Registration Number: NCT03935581

Locations: 🇨🇦
Sunnybrook, Toronto, Ontario, Canada
🇰🇷
Yonsei University Health System, Severance Hospital, Seoul, Seodaemun-gu, Korea, Republic of

ExAblate Blood-Brain Barrier Opening for Treatment of Alzheimer's Disease

Not Applicable

Recruiting

Conditions: Alzheimer Disease

Interventions: Device: Blood Brain Barrier (BBB) Disruption

First Posted Date: 2018-11-14

Last Posted Date: 2023-03-02

Lead Sponsor: InSightec

Target Recruit Count: 30

Registration Number: NCT03739905

Locations: 🇨🇦
Division of Neurosurgery, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada

Blood Brain Barrier Disruption (BBBD) Using MRgFUS in the Treatment of Her2-positive Breast Cancer Brain Metastases

Not Applicable

Conditions: Brain Metastases
Breast Cancer

Interventions: Device: ExAblate BBBD

First Posted Date: 2018-10-22

Last Posted Date: 2021-08-24

Lead Sponsor: InSightec

Target Recruit Count: 10

Registration Number: NCT03714243

Locations: 🇨🇦
Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada

ExAblate Blood-Brain Barrier Disruption for Glioblastoma in Patients Undergoing Standard Chemotherapy

Not Applicable

Completed

Conditions: Glioblastoma Multiforme

Interventions: Device: BBB Disruption with Chemotherapy Arm

First Posted Date: 2018-10-19

Last Posted Date: 2024-03-05

Lead Sponsor: InSightec

Target Recruit Count: 9

Registration Number: NCT03712293

Locations: 🇰🇷
Severance Hospital, Yonsei University Health System, Seoul, Seodaemun-gu, Korea, Republic of

ExAblate Blood-Brain Barrier (BBB) Disruption for the Treatment of Alzheimer's Disease

Not Applicable

Recruiting

Conditions: Alzheimer Disease

Interventions: Device: Blood Brain Barrier (BBB) Disruption

First Posted Date: 2018-09-14

Last Posted Date: 2024-10-08

Lead Sponsor: InSightec

Target Recruit Count: 150

Registration Number: NCT03671889

Locations: 🇺🇸
Advent Health, Orlando, Florida, United States
🇺🇸
Delray Medical Center & Florida Atlantic University, Delray Beach, Florida, United States
🇺🇸
Broward Health Medical Center & The University of Florida, Fort Lauderdale, Florida, United States

and more 7 locations

Assessment of Safety and Feasibility of ExAblate Blood-Brain Barrier (BBB) Disruption for Treatment of Glioma

Not Applicable

Completed

Conditions: Glioblastoma

Interventions: Device: Focused Ultrasound (FUS) BBB Disruption

First Posted Date: 2018-08-06

Last Posted Date: 2024-01-23

Lead Sponsor: InSightec

Target Recruit Count: 14

Registration Number: NCT03616860

Locations: 🇨🇦
Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy